Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insights from factor IX activation studies with chromogenic assays: implications of disparate product results.

× No keyword cloud information.

4 in total

1. Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab.

Authors: Yesim Dargaud; Anne Lienhart; Maissaa Janbain; Sandra Le Quellec; Nathalie Enjolras; Claude Negrier
Journal: Haematologica Date: 2018-02-22 Impact factor: 9.941

2. Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples.

Authors: Jurg M Sommer; Ali Sadeghi-Khomami; Christopher Barnowski; Margareta Wikén; Annemieke J Willemze
Journal: Int J Lab Hematol Date: 2020-03-23 Impact factor: 2.877

3. Recombinant FIX Fc fusion protein activity assessment with the one-stage clotting assay: A multicenter, assessor-blinded, prospective study in Japan (J-Field Study).

Authors: Katsuyuki Fukutake; Tomomi Kobayashi; Jurg M Sommer; Toshiyuki Hirakata
Journal: Int J Lab Hematol Date: 2019-12-10 Impact factor: 2.877

4. Activity measurements of dalcinonacog alfa.

Authors: Stella C Williams; Elaine Gray
Journal: Haemophilia Date: 2020-03-06 Impact factor: 4.287

4 in total